Avalo Therapeutics, Inc. · NASDAQ:AVTX

Point72 Asset Management, L.P. reported a 5.40% stake in Avalo Therapeutics, Inc. (Schedule 13G)

Event Aug 4, 2025 · Filed Aug 5, 2025

Point72 Asset Management, L.P. reported a 5.40% stake in Avalo Therapeutics, Inc., 588,632 shares, as a passive investor on Aug 4, 2025. Filed Aug 5, 2025 (Schedule 13G).

Stake
5.40%
Shares
588,632
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.5.40%588,632
Point72 Capital Advisors, Inc.5.40%588,632
Steven A. Cohen5.40%588,632

Source

View original at SEC

Related